|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 07:00 10-May-2013 | XEN | Commencement of Phase II with MyeloXenT | RNS | +8.49% |
| 07:00 09-May-2013 | XEN | Commencement of dosing in Phase III study | RNS | +11.32% |
| 07:00 30-Apr-2013 | XEN | Entrepreneur acquires 10% of Pharmsynthez | RNS | -1.85% |
| 08:26 18-Apr-2013 | XEN | Statement regarding OTC Bulletin Board | RNS | -5.05% |
| 07:00 12-Apr-2013 | XEN | Xenetic Biosciences attended MassEcon Reception | RNS | +17.31% |
| 07:00 20-Mar-2013 | XEN | Selected to Present at BioTrinity | RNS | -1.14% |
| 14:23 15-Feb-2013 | XEN | New Investor Presentation | RNS | -6.51% |
| 07:00 13-Feb-2013 | XEN | Research Agreement on OncoHist | RNS | -7.99% |
| 07:00 21-Nov-2012 | XEN | Schedule Two (g) update | RNS | -3.33% |
| 07:00 19-Nov-2012 | XEN | Adviser Change of Name | RNS | -5.96% |
| 07:00 19-Nov-2012 | XEN | Commencement of Phase I/II(a) clinical trial | RNS | -5.96% |
| 07:00 04-Oct-2012 | XEN | Broadening in the US of IP portfolio | RNS | +1.69% |
| 07:00 01-Oct-2012 | XEN | Analyst and Investor Conference call | RNS | -0.82% |
| 07:00 27-Sep-2012 | XEN | Half Yearly Report | RNS | -5.58% |
| 07:00 05-Sep-2012 | XEN | Scientific Advisory Board Appointments | RNS | 0.00% |
| 07:00 05-Jul-2012 | XEN | Scientific Advisory Board ("SAB") Appointments | RNS | 0.00% |
| 11:22 28-Jun-2012 | XEN | Result of AGM | RNS | -3.41% |
| 07:00 13-Jun-2012 | XEN | Relocation of Drug Development Program | RNS | +7.23% |
| 07:00 06-Jun-2012 | XEN | Final Results | RNS | 0.00% |
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds